AI assistant
Sending…
AVIENT CORP — Director's Dealing 2024
Jan 9, 2024
31389_dirs_2024-01-09_0efb1386-38a2-4162-9c98-a0dcfbb6cfc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVIENT CORP (AVNT)
CIK: 0001122976
Period of Report: 2024-01-08
Reporting Person: Rathbun Joel R. (SVP, Mergers & Acquisitions)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-08 | Common Stock | M | 2400 | $35.07 | Acquired | 7734 | Direct |
| 2024-01-08 | Common Stock | D | 2259 | $38.545 | Disposed | 5475 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-08 | Stock Appreciation Rights | $35.07 | M | 2400 | Disposed | 2024-02-11 | Common Stock (2400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 28072.826 | Indirect |
Footnotes
F1: The information in this report is based on a plan statement as of January 8, 2024.
F2: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.
More from AVIENT CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24